| Burgstahler David FDirector, 10% owner · 15 transactions | — | 5.57M†as of Apr 2017 | 24.0K | — | 6.69M |
| Stern Linda B10% owner · 40 transactions | — | 3.15M†as of Dec 2006 | 188.7K | — | 77.1K |
| Avista Capital Partners (Offshore), L.P. +3 co-filers10% owner · 9 transactions | — | 2.33M†as of Apr 2017 | — | — | 6.68M |
| Clemmer James CPresident and CEO, Director · 56 transactions | — | 882.5K | 1.06M | 140.0K | — |
| Meyers David PDirector · 24 transactions | — | 357.0Kas of Aug 2006 | 30.0K | — | 114.1K |
| Trowbridge Stephen AEVP and CFO · 83 transactions | — | 256.6K | 311.9K | 5.7K | 12.9K |
| Bucci VincentDirector · 18 transactions | — | 235.0K†as of Oct 2013 | 11.2K | 107.0K | — |
| Devivo JosephPresident and CEO, Director · 21 transactions | — | 198.5Kas of Sep 2015 | 207.4K | 12.5K | — |
| Donnelly Howard WDirector · 34 transactions | — | 167.1Kas of Jul 2025 | 217.1K | 10.0K | 20.0K |
| Graham Peter JDirector · 1 transaction | — | 166.1K†as of Oct 2006 | 1.5K | — | — |
| Echenberg Paul SDirector Emeritus · 16 transactions | — | 154.4Kas of Apr 2012 | 92.8K | — | — |
| Johnson WesleyDirector · 35 transactions | — | 143.5Kas of Jul 2025 | 197.8K | 6.4K | 14.0K |
| Meteny Dennis SDirector · 33 transactions | — | 140.0Kas of Jul 2023 | 182.9K | 4.6K | — |
| Keltjens JanPresident & CEO, Director · 8 transactions | — | 109.3Kas of Jan 2011 | 110.0K | 15.0K | — |
| Reed Jan SternDirector · 10 transactions | — | 105.0Kas of Jul 2025 | 104.7K | 316 | — |
| Auen Eileen O'SheaDirector · 9 transactions | — | 104.7Kas of Jul 2025 | 104.7K | — | — |
| Hobbs Eamonn PPresident & CEO, Director · 57 transactions | — | 100.4Kas of Feb 2009 | 270.7K | 3.7K | 219.1K |
| Weiss Lawrence TSVP, Chief Legal Officer · 3 transactions | — | 93.6K | 83.6K | 10.0K | — |
| Campbell Chad ThomasSVP/GM, Vascular Access · 47 transactions | — | 92.3Kas of Jul 2025 | 111.1K | — | 10.7K |
| Licitra Karen ADirector · 7 transactions | — | 90.4Kas of Jul 2025 | 90.4K | — | — |
| Gold JeffreyDirector · 30 transactions | — | 83.6Kas of Jul 2019 | 111.5K | 1.0K | — |
| Tarnoff Michael EDirector · 6 transactions | — | 83.4Kas of Jul 2025 | 83.4K | — | — |
| Gould Kevin JDirector · 20 transactions | — | 77.5Kas of Jul 2020 | 113.3K | 8.1K | 13.7K |
| Nighan Warren JRSVP Quality and Regulatory · 16 transactions | — | 69.9Kas of Jul 2025 | 60.4K | 868 | 4.1K |
| Piccinini LauraSVP International · 16 transactions | — | 66.8Kas of Jul 2025 | 80.4K | — | — |
| Centea ScottSVP/GM, VIT · 13 transactions | — | 58.1Kas of Jul 2023 | 33.8K | — | 12.0K |
| Burgess LorindaDirector · 3 transactions | — | 55.3Kas of Jul 2025 | 55.3K | — | — |
| LaPorte SteveDirector · 24 transactions | — | 48.5Kas of Jul 2018 | 70.3K | 8.8K | — |
| Gersuk D JosephEVP - CFO · 13 transactions | — | 47.3Kas of Sep 2012 | 43.7K | — | — |
| Frost Mark TEVP and CFO · 8 transactions | — | 38.4Kas of Aug 2015 | 40.1K | — | — |
| Greiner MichaelEVP and CFO · 12 transactions | — | 33.4Kas of Aug 2019 | 41.2K | — | 1.9K |
| Richard StarkSVP, GM - Oncology · 33 transactions | — | 30.8Kas of Nov 2017 | 73.5K | — | 50.7K |
| Kapusta Matthew CSVP, Business Development · 12 transactions | — | 30.1Kas of Nov 2014 | 30.2K | 2.0K | — |
| Helsel DaveSVP Global Operations and R&D · 26 transactions | — | 28.3Kas of Jul 2023 | 50.0K | — | 20.1K |
| Panzer AlanSVP, GM - Vascular · 2 transactions | — | 27.5Kas of Aug 2012 | 27.5K | — | — |
| Bourne George W. IVCTO and COO · 8 transactions | — | 23.6Kas of Aug 2014 | 23.4K | — | — |
| Soto JohnSVP and CCO · 10 transactions | — | 22.5Kas of Sep 2015 | 26.6K | — | — |
| Greiner Charles RVP - Global Franchise · 23 transactions | — | 20.9Kas of May 2016 | 32.3K | — | 15.1K |
| McGill StephenSVP, GM - International · 14 transactions | — | 20.7Kas of Jan 2014 | 39.9K | — | — |
| Appling William MVice-President - Research · 14 transactions | — | 16.6Kas of Sep 2010 | 25.3K | — | 14.0K |
| Rosenzweig Richard CSVP and General Counsel · 4 transactions | — | 15.7Kas of Feb 2023 | 15.0K | — | — |
| Simpson Robert ArthurSVP/GM, Global Vascular · 10 transactions | — | 15.4Kas of Jul 2019 | 24.1K | — | — |
| Boucher Brent J.SVP and GM of Oncology · 6 transactions | — | 15.4Kas of Feb 2020 | 3.2K | — | — |
| Mapes HaroldVP - Operations · 8 transactions | — | 14.9Kas of Sep 2010 | 10.6K | — | — |
| McCarthy Shawn PSVP - General Manager · 2 transactions | — | 10.4Kas of Aug 2010 | 8.0K | — | — |
| Rossell Robert MVP - Marketing · 7 transactions | — | 8.9Kas of Oct 2009 | 5.8K | — | — |
| Solano Scott J.Interim CEO · 3 transactions | — | 8.9Kas of Aug 2011 | 10.6K | — | — |
| Shea Paul JVP - Sales · 3 transactions | — | 7.7Kas of Aug 2007 | 6.1K | — | 5.1K |
| Etlinger Richard ScottSVP - Global Operations · 3 transactions | — | 5.5Kas of Aug 2012 | 12.5K | — | — |
| Gerardi Joseph GVice President · 25 transactions | — | 5.1Kas of Aug 2007 | 28.5K | — | 24.0K |
| Orsatti Charles ThomasDirector · 1 transaction | — | 4.0Kas of Aug 2010 | — | 2.0K | — |
| Flaherty Robert EDirector · 1 transaction | — | 3.7Kas of Aug 2008 | 2.5K | — | — |
| Kunst BrianVP - Regulatory Affairs · 2 transactions | — | 1.5Kas of Aug 2007 | 1.5K | — | — |
| Mitchell Robert DExecutive VP and COO · 2 transactions | — | 1.2Kas of Aug 2007 | 1.2K | — | — |
| Recinella DanielVP - Product Development · 4 transactions | — | 1.2Kas of Aug 2007 | 4.0K | — | 3.5K |